Anticancer Res
- LEE YJ, Baek JH, Kim JG, Park KB, et al
Clinical Significance of PD-L1, LAG3, and VISTA in Patients With Poorly Cohesive
Cell Gastric Cancer.
Anticancer Res. 2025;45:3939-3951.
- TAKABATAKE K, Kubota T, Inoue H, Nishibeppu K, et al
Prevalence and Clinical Impact of Severe Periodontitis in Patients With Gastric
Cancer.
Anticancer Res. 2025;45:3885-3894.
- KATAYAMA R, Aoki T, Matsuda K, Yamazaki K, et al
Assessment of Remnant Gastric Perfusion Using Indocyanine Green During
Pancreaticoduodenectomy After Gastrectomy: A Case Report.
Anticancer Res. 2025;45:4057-4062.
BMC Cancer
- SHANSHAN W, Lian W, Lu D, Liping L, et al
Best practices for home nutritional management in postoperative gastric cancer
patients: an evidence summary.
BMC Cancer. 2025;25:1399.
- ZHANG R, Chen X, Chen G, Zhao Z, et al
Novel surveillance protocol for gastric cancer based on CEA: a high-volume
multi-center study.
BMC Cancer. 2025;25:1396.
- ZENG T, Ling X, Chen S, Yang J, et al
Prognostic value of nutritional risk assessment indices in patients with
digestive system tumors.
BMC Cancer. 2025;25:1385.
BMC Gastroenterol
- WANG X, Jiang H, Liang M, Cai D, et al
A Multi-marker model based on serum IL-10 predicts response to conversion
immunochemotherapy in gastric cancer patients: a retrospective cohort study.
BMC Gastroenterol. 2025;25:621.
Br J Cancer
- LI L, Yin J, Zhang L, Liu W, et al
Aberrant PJA2-CHRM3 signaling creates a therapeutic vulnerability in gastric
tumor.
Br J Cancer. 2025 Aug 26. doi: 10.1038/s41416-025-03145.
Endoscopy
- SONG S, Liu H, Geng X, Chen R, et al
Assessment of the participation rate and effectiveness of upper gastrointestinal
cancer screening in China: a multicenter population-based screening study.
Endoscopy. 2025;57:972-979.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016